Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

Inge G. P. Geelen; Stein-Erik Gullaksen; Mette M. Ilander; Ulla Olssen-Strömberg; Satu Mustjoki; Johan Richter; Nicole M. A. Blijlevens; Willem M. Smit; Bjorn T. Gjertsen; Tobias Gedde-Dahl; Berit Markevarn; Malika M. A. Koppes; Peter E. Westerweel; Henrik Hjorth-Hansen; Jeroen J. W. M. Janssen

doi:10.1007/s00277-023-05199-1

Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

Inge G. P. Geelen, Stein-Erik Gullaksen, Mette M. Ilander, Ulla Olssen-Strömberg, Satu Mustjoki, Johan Richter, Nicole M. A. Blijlevens, Willem M. Smit, Bjorn T. Gjertsen, Tobias Gedde-Dahl, Berit Markevarn, Malika M. A. Koppes, Peter E. Westerweel, Henrik Hjorth-Hansen, Jeroen J. W. M. Janssen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Annals of Hematology
Volym	102
Nummer	6
Sidor (från-till)	1395–1408
Antal sidor	14
ISSN	0939-5555
DOI	https://doi.org/10.1007/s00277-023-05199-1
Status	Publicerad - juni 2023
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1007/s00277-023-05199-1

Citera det här

Geelen, I. G. P., Gullaksen, S.-E., Ilander, M. M., Olssen-Strömberg, U., Mustjoki, S., Richter, J., Blijlevens, N. M. A., Smit, W. M., Gjertsen, B. T., Gedde-Dahl, T., Markevarn, B., Koppes, M. M. A., Westerweel, P. E., Hjorth-Hansen, H., & Janssen, J. J. W. M. (2023). Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. Annals of Hematology, 102(6), 1395–1408 . https://doi.org/10.1007/s00277-023-05199-1

@article{7dd99025d1a54e0dabc01ebf0b8d0a4c,

title = "Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects",

keywords = "Chronic myeloid leukemia, Immunology, Molecular response, Nilotinib, Pegylated interferon-alfa2b, Quality of life, 3122 Cancers",

author = "Geelen, {Inge G. P.} and Stein-Erik Gullaksen and Ilander, {Mette M.} and Ulla Olssen-Str{\"o}mberg and Satu Mustjoki and Johan Richter and Blijlevens, {Nicole M. A.} and Smit, {Willem M.} and Gjertsen, {Bjorn T.} and Tobias Gedde-Dahl and Berit Markevarn and Koppes, {Malika M. A.} and Westerweel, {Peter E.} and Henrik Hjorth-Hansen and Janssen, {Jeroen J. W. M.}",

year = "2023",

month = jun,

doi = "10.1007/s00277-023-05199-1",

language = "English",

volume = "102",

pages = "1395–1408 ",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer",

number = "6",

}

Geelen, IGP, Gullaksen, S-E, Ilander, MM, Olssen-Strömberg, U, Mustjoki, S, Richter, J, Blijlevens, NMA, Smit, WM, Gjertsen, BT, Gedde-Dahl, T, Markevarn, B, Koppes, MMA, Westerweel, PE, Hjorth-Hansen, H & Janssen, JJWM 2023, 'Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects', Annals of Hematology, vol. 102, nr. 6, s. 1395–1408 . https://doi.org/10.1007/s00277-023-05199-1

Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects. / Geelen, Inge G. P.; Gullaksen, Stein-Erik; Ilander, Mette M. et al.
I: Annals of Hematology, Vol. 102, Nr. 6, 06.2023, s. 1395–1408 .

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response

T2 - clinical and immunological effects

AU - Geelen, Inge G. P.

AU - Gullaksen, Stein-Erik

AU - Ilander, Mette M.

AU - Olssen-Strömberg, Ulla

AU - Mustjoki, Satu

AU - Richter, Johan

AU - Blijlevens, Nicole M. A.

AU - Smit, Willem M.

AU - Gjertsen, Bjorn T.

AU - Gedde-Dahl, Tobias

AU - Markevarn, Berit

AU - Koppes, Malika M. A.

AU - Westerweel, Peter E.

AU - Hjorth-Hansen, Henrik

AU - Janssen, Jeroen J. W. M.

PY - 2023/6

Y1 - 2023/6

KW - Chronic myeloid leukemia

KW - Immunology

KW - Molecular response

KW - Nilotinib

KW - Pegylated interferon-alfa2b

KW - Quality of life

KW - 3122 Cancers

U2 - 10.1007/s00277-023-05199-1

DO - 10.1007/s00277-023-05199-1

M3 - Article

C2 - 37119314

SN - 0939-5555

VL - 102

SP - 1395

EP - 1408

JO - Annals of Hematology

JF - Annals of Hematology

IS - 6

ER -